Salonpas patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9233184 HISAMITSU PHARM CO Adhesive preparation
Aug, 2027

(3 years from now)

US8809615 HISAMITSU PHARM CO Adhesive preparation
Jan, 2030

(6 years from now)

Salonpas is owned by Hisamitsu Pharm Co.

Salonpas contains Menthol; Methyl Salicylate.

Salonpas has a total of 2 drug patents out of which 0 drug patents have expired.

Salonpas was authorised for market use on 20 February, 2008.

Salonpas is available in patch;topical dosage forms.

The generics of Salonpas are possible to be released after 03 January, 2030.

Drugs and Companies using MENTHOL; METHYL SALICYLATE ingredient

Market Authorisation Date: 20 February, 2008

Treatment: NA


More Information on Dosage

SALONPAS family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic